Company overview
Luminex provides xMAP technology, a multiplexed assay platform that enables simultaneous analysis of up to 500 analytes like cytokines, chemokines, and growth factors from minimal sample volumes. It combines proprietary microspheres, advanced fluidics, optics, and digital signal processing for high-throughput quantification in a single reaction. The technology supports applications in biomarker discovery, preclinical studies, inflammation, cancer, and metabolic disease research.
Luminex’s Licensed Technology is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include luminex xmap, multiplex assays, cytokine analysis, biomarker discovery, high-throughput proteomics.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Luminex’s Licensed Technology include Assay — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.luminexcorp.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- luminex xmap, multiplex assays, cytokine analysis, biomarker discovery, high-throughput proteomics
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What analytes can Luminex xMAP technology measure?
- Luminex xMAP measures up to 500 analytes including cytokines, chemokines, growth factors, hormones, adipokines, proteins, and genes in a single low-volume sample.
- What are the key capabilities of Luminex platforms for high-throughput research?
- Luminex platforms offer multiplexing up to 96-500 analytes, small sample volumes, high sensitivity, automation, and compatibility with 384-well plates for rapid processing in biomarker discovery and preclinical studies.
- What industries or applications does Luminex serve?
- Luminex serves life sciences and pharma in areas like inflammation, cancer, metabolic disease, neurodegenerative disease, toxicity, immune response screening, and clinical diagnostics using flow cytometry-based bead analysis.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
